In gastric cancer, miR-200b overexpression stimulates proliferation, cell invasion, and EMT, thereby suppressing tumor development and increasing sensitivity to the anticancer drug cisplatin through negative regulation of HMGB3 [234]. This evidence concerns the gene HMGB3 and gastric cancer.